US Rheumatologists Believe Biogen’s Litifilimab Is the Leading SLE Pipeline Asset Poised to Offer Improvement Over Benlysta and Saphnelo Based on Clinical Trial Data
12 sept. 2024 16h36 HE
|
Spherix Global Insights
EXTON, PA, Sept. 12, 2024 (GLOBE NEWSWIRE) -- The systemic lupus erythematosus (SLE) advanced treatment landscape is poised for evolution, with multiple new therapies in development to treat this...
Long Term Investor News: Biogen, Seritage Growth, Arbor Realty, and Five Below Investors are Encouraged to Contact Johnson Fistel, LLP for Their Options
26 août 2024 10h15 HE
|
Johnson Fistel, LLP
SAN DIEGO, Aug. 26, 2024 (GLOBE NEWSWIRE) -- Johnson Fistel, LLP is conducting a thorough investigation into possible violations of securities laws by specific officers at Biogen Inc. (NASDAQ:...
BIOGEN ALERT: Bragar Eagel & Squire, P.C. is Investigating Biogen Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm
25 juil. 2024 21h00 HE
|
Bragar Eagel & Squire
NEW YORK, July 25, 2024 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, is investigating potential claims against Biogen Inc. (NASDAQ: BIIB)...
SHAREHOLDER NOTICE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Biogen
18 juil. 2024 10h05 HE
|
Faruqi & Faruqi LLP
Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Biogen To Contact Him Directly To Discuss Their Options If you purchased or acquired securities in...
BIIB Investors Have Opportunity to Lead Biogen Inc. Securities Fraud Lawsuit with the Schall Law Firm
16 juil. 2024 10h20 HE
|
Schall Law
BIIB Investors Have Opportunity to Lead Biogen Inc. Securities Fraud Lawsuit with the Schall Law Firm
BIOGEN INC. (NASDAQ: BIIB) SHAREHOLDER ALERT: Only 7 Days Remain For Investors To Move For Lead Plaintiff in Biogen Inc.
15 juil. 2024 14h27 HE
|
Bernstein Liebhard LLP
Only 7 Days Remain For Investors To Move For Lead Plaintiff in Biogen Inc.
DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Biogen
12 juil. 2024 10h15 HE
|
Faruqi & Faruqi LLP
Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Biogen To Contact Him Directly To Discuss Their Options If you purchased or acquired securities in Biogen...
BIIB Investors Have Opportunity to Lead Biogen Inc. Securities Fraud Lawsuit with the Schall Law Firm
09 juil. 2024 11h00 HE
|
Schall Law
BIIB Investors Have Opportunity to Lead Biogen Inc. Securities Fraud Lawsuit with the Schall Law Firm
Biogen Inc. Investors: Class action lawsuit filed on behalf of investors; the Portnoy Law Firm
09 juil. 2024 09h00 HE
|
Portnoy Law
Investors can contact the law firm at no cost to learn more about recovering their losses. LOS ANGELES, July 09, 2024 (GLOBE NEWSWIRE) -- The Portnoy Law Firm advises Biogen Inc....
BIOGEN INC. (NASDAQ: BIIB) DEADLINE ALERT: Bernstein Liebhard LLP Reminds Biogen Inc. Investors of Upcoming Deadline
08 juil. 2024 10h49 HE
|
Bernstein Liebhard LLP
Bernstein Liebhard LLP Reminds Biogen Inc. Investors of Upcoming Deadline